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on days -1, 0, and 2. Mice were transplanted with T cells and BM
from either syngeneic B6 or allogeneic BALB/c donors. Injection of
SAHA treated DCs resulted in better survival (60% vs. 10%, P 
0.05) and signiﬁcantly reduced serum levels of TNF- and donor T
cell expansion compared to the controls. Together our data demon-
strate a novel IDO dependent mechanism for HDAC inhibitor me-
diated immuno-modulation of DCs and regulation of GVHD.
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Chronic graft-versus-host disease (GVHD) continues to be the
most common late complication after allogeneic bone marrow
transplantation (BMT) and the basic pathophysiology of chronic
GVHD remains poorly deﬁned. We have previously demonstrated
that donor bone marrow-derived T cells differentiated via im-
paired thymus of the recipients cause chronic GVHD after allo-
geneic transplantation of T cell-depleted bone marrow (TCD
BM). Lethally irradiated C3H/HeN (H-2k) recipients of TCD BM
cells from MHC class II-deﬁcient (H2Ab1-/-) B6 (H-2b) mice
developed GVHD showing clinical and histopathological features
of human chronic GVHD. We further studied mechanism of
chronic GVHD in this model. A ﬂowcytometric analysis showed
that the numbers of CD4CD25foxp3 regulatory T cells were
comparable between [WT3C3H] and [H2-Ab1-/-3 C3H] mice.
Thymectomy prevented chronic GVHD, thus suggesting the
causal association of the thymus. We then investigated reactivity of
pathogenic CD4 T cells in [H2-Ab1-/- 3 C3H] mice. A ﬂow
cytometric analysis of cell division of CFSE-labeled donor T cells
demonstrated that [H2-Ab1-/- 3 C3H] CD4 T cells divided to
B6 stimulators, but not to C3H stimulators. A ﬂowcytometric
analysis of intracytoplasmic IL-4 and IFN-g suggested polarization
of these cells toward Th1 cytokine responses. Adoptive transfer of
[H2Ab1-/-3 C3H] CD4 T cells caused severe and lethal disease
in B6 recipients. All mice died by day 40 post-BMT and a patho-
logical analysis of the liver and intestine showed standard patho-
logical features of acute GVHD. In contrast, the transfer of [H2-
Ab1-/-3 C3H] CD4 T cells did not cause GVHD in C3H
recipients. Thus, both in vitro and in vivo experiments demon-
strated that these pathogenic CD4 T cells were primarily B6
reactive. Interestingly, the transfer of these cells caused chronic
GVHD in C3H recipients similar to the primary [H2-Ab1-/- 3
C3H] mice in the presence of B6-derived antigen-presenting cells
(APCs). To further conﬁrm the requirement of B6-derived APCs
for the disease, we created [B6 3 C3H] and [C3H 3 C3H]
chimeras. The transfer of [H2-Ab1-/-3 C3H] CD4 T cells did
caused chronic GVHD only in the [B63 C3H] chimeras, but not
in the [C3H 3 C3H] chimeras, thus conﬁrming the requirement
of B6- derived APCs for the transmission of the disease to second-
ary recipients. These results suggest that self-reactivity of donor
Th1 cells play a role in this chronic GVHD.
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The immunological activity of donor T-cells following alloge-
neic BMT is determined by the initial interaction of T-cells with
antigen presenting cells (APC) in the recipient. While previous
reports have established a requirement for host APC in the initi-
ation of GvHD, we have explored the role of donor APC as
positive and negative regulatory elements in the activation of allo-
reactive donor T-cells. We have previously published that alloge-
neic donor BM enriched for CD11b- dendritic cells (DC) pro-
motes enhanced donor T-cell chimerism and GvL, suggesting that
donor DC subsets modulate immune reconstitution post-BMT
(Li, Waller. BBMT 2004). In this study, we examined the immune
polarization capabilities and co-stimulator expression of FACS-
puriﬁed CD11b and CD11b- DC subsets in allogeneic BMT and
their effect on survival, GvL, GvHD, and immune reconstitution.
Fifty thousand puriﬁed CD11b DC or CD11b- DC from
C57BL/6 donors were transplanted along with 5,000 puriﬁed Lin-
,Sca-1,C-kit hematopoietic stem cells (HSC) and 300,000 con-
geneic spleen T-cells into C57BL/6 [H-2Kb] and B10BR [H-2Kk]
recipient mice. The cytokine production, immune proliferation,
and Ki-67 expression of CFSE-labeled donor T-cells were evalu-
ated. Additionally, DC subsets were analyzed by ﬂow cytometry for
co-stimulator expression, including PD-L1, PD-L2, CD80, and
CD86. In tumor free mice, recipients of HSC alone or HSC
combined with CD11b DC or CD11b- DC did not differ in
survival or GvHD over 100 days post allo-BMT. Recipients of
CD11b- DC had increased GvL and donor T-cell proliferation at
days 10, 30, 60, and 105, resulting in full-donor T-cell chimerism.
In contrast, recipients of CD11bDC had mixed T-cell chimerism
and increased numbers of immunosuppressive donor
CD4CD25Foxp3T-cells. Phenotypic and functional analysis
of CD11b and CD11b- DC revealed that CD11b DC had
higher levels of immunosuppressive co-stimulators PD-L1 and
PD-L2, while CD11b- DC induced higher levels of IL-12 and
IFN- when co-cultured with syngeneic T-cells. In conclusion,
donor CD11b- DC promote immune reconstitution and GvL and
polarize donor T-cells to Th1 immune responses, while donor
CD11b DC suppress immune reconstitution by expressing sup-
pressive co-stimulators and promoting tolerant donor Treg cells.
Donor Graft Cells and Survival
Experimental
Group
Number of
Mice
DC
Subset
Tumor
Cells
Survival
(100 days
post-BMT)
HSC alone 40 none none 90%
HSC alone 20 none LBRM 0%
HSC  T-cells 40 none none 80%
HSC  T-cells 20 none LBRM 0%
HSC  T-cells 
DC 40 CD11b- none 80%
HSC  T-cells 
DC 20 CD11b- LBRM 40%***
HSC  T-cells 
DC 40 CD11b none 80%
HSC  T-cells 
DC 20 CD11b LBRM 0%
HSC5,000 lin-, sca-1, c-kit bone marrow cells; T-cells
300,000 splenic T-cells; DC 50,000 FACS sorted CD11b- or
CD11b dendritic cell subsets; LBRM 100,000 T-lympho-
blastic leukemic cells; *** p0.01 compared to other groups
with LBRM
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